U.S. Markets open in 32 mins

Company News For Nov 27, 2018

Vanguard invests in a variety of sectors that are sensitive, cyclical and defensive.
  • Zafgen, Inc.’s ZFGN shares plummeted 40.6% after the FDA put U.S. trials of the company’s experimental diabetes drug on hold, citing safety concerns
  • Shares of Cleveland-Cliffs Inc. CLF declined 1.3% after it announced a new $200 million stock buyback program
  • Aetna. Inc.’s AET shares gained 2.3% after CVS Health Corporation CVS received the final regulatory nod to acquire the company
  • Shares of GW Pharmaceuticals plc GWPH increased 2.9% after the company announced positive top-line results for its cannabinoid-based childhood-onset epilepsy treatment, Epidiolex


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
GW Pharmaceuticals PLC (GWPH) : Free Stock Analysis Report
 
Zafgen, Inc. (ZFGN) : Free Stock Analysis Report
 
Aetna Inc. (AET) : Free Stock Analysis Report
 
Cleveland-Cliffs Inc. (CLF) : Free Stock Analysis Report
 
CVS Health Corporation (CVS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research